Karin Jordan, MD, PhD - Practical Protocols for Preventing and Managing Antibody-Drug Conjugate-Associated Nausea and Vomiting

Visit https://www.peervoice.com/NFQ860 to view the entire programme with slides. After completing “Karin Jordan, MD, PhD - Practical Protocols for Preventing and Managing Antibody-Drug Conjugate-Associated Nausea and Vomiting”, participants will be able to: Recall the emetogenic risk of approved antibody-drug conjugates (ADCs); Explain why it is imperative for ADC-associated nausea and vomiting to be optimally controlled from the beginning; Outline the guidelines for control of emesis for anticancer treatments that have a moderate-high/high emetogenic risk; and Propose appropriate protocols to prevent and manage ADC-associated nausea and vomiting.